Switzerland· 55937036
Arixtra
A fondaparinux product containing fondaparinuxum natricum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Fondaparinux is registered in 17 of 19 countries.
Countries holding a registration under ATC B01AX05 (fondaparinux), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 11 of them publish a price we can compare per daily dose
Fondaparinux · ATC B01AX05
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- fondaparinuxum natricum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- B01AX05
- ATC class
- Fondaparinux
- Defined daily dose
- 2.5 mg, P
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768055937036110 Fertspr 0.8 mlCHF 181.75
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
158 interactions on record for fondaparinux.
Graded by severity as the source publishes them — 106 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fondaparinux · interactions on record
158 records
- 106 severe
- 52 moderate
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- Antithrombin IIIB01AB02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fondaparinux in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaARIXTRAVIATRIS HEALTHCARE LIMITED, Dublin
- FinlandQuixidarGlaxo Group Ltd
- IcelandArixtraViatris Healthcare Limited
- PolandArixtraViatris Healthcare Limited
- BelgiumArixtra 10 mg/0.8 mlViatris Healthcare
- SwedenArixtra 10 mg/0,8 ml Injektionsvätska, lösning i förfylld sprutaViatris Healthcare Limited
- SpainARIXTRA 5 MG/0,4 ML SOLUCION INYECTABLE, JERINGA PRECARGADAViatris Healthcare Limited
- United StatesArixtraMylan Institutional LLC
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Germany · Fondaparinux-Natrium Beta
- France · Fondaparinux Sodique Aspen
- United Kingdom (Northern Ireland) · Fondaparinux Sodium Dr. Reddy's
- Ireland · Fondaparinux Sodium Aspen
- Iceland · Arixtra
- Liechtenstein · Arixtra
- Norway · Arixtra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d49dbff1-23dc-487a-92fa-8bf126365366 GET /v1/drugs/d49dbff1-23dc-487a-92fa-8bf126365366?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "fondaparinuxum natricum 10 mg",
"valid_from": "2006-09-01",
"limitations": null,
"galenic_form": "Inj Lös 10 mg/0.8ml",
"therapeutic_area": null,
"sl_inclusion_date": "2006-09-01",
"self_retention_pct": 10
}See everything about fondaparinux.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.